She points to inflammation as another area that might grow with this GLP-1 audience. Foodtech innovation pipeline The GLP-1 market, and consumers more broadly, are demanding better-for-you products, and ingredient companies are listening
In a double-blind clinical trial in Denmark, 52 patients (mean age, 50.2 years) with verified bile acid diarrhea received either one daily subcutaneous injection of liraglutide (increasing from 0.6-1.8 mg per day over 3 weeks) or standard-of-care colesevelam (three capsules of 625 mg twice daily) for 6 weeks following one run-in week with no treatment
Flag monoclonal antibodies were used for IP testing, followed by immunoblotting using anti-Flag (ab49763
Patients were to be randomized to 1200 mg, 450 mg, or placebo, administered intravenously daily for 3 days followed by weekly for 4 weeks
The company launched in November 2024 with a specific mission: provide physician-formulated nutritional support for people using GLP-1 receptor agonist medications for weight management
